RESUMO
The present study was aimed to develop and evaluate a microemulsion-based dermal drug delivery of an antiviral agent, acyclovir. A water-in-oil microemulsion was prepared using isopropyl myristate, Tween 20, Span 20, water and dimethylsulphoxide. It was characterized for drug content, stability, globule size, pH, viscosity and ex vivo permeation through mice skin. In vivo antiviral efficacy of optimized formulation was assessed in female Balb/c mice against herpes simplex virus-I (HSV-I)-induced infection. It was observed that optimized formulation when applied 24-h post-infection could completely inhibit the development of cutaneous herpetic lesions vis-à-vis marketed cream.
Assuntos
Aciclovir/química , Aciclovir/farmacologia , Portadores de Fármacos/química , Herpesvirus Humano 1/efeitos dos fármacos , Óleos/química , Água/química , Aciclovir/metabolismo , Aciclovir/uso terapêutico , Animais , Modelos Animais de Doenças , Composição de Medicamentos , Emulsões , Feminino , Herpes Simples/tratamento farmacológico , Herpesvirus Humano 1/fisiologia , Camundongos , Camundongos Endogâmicos BALB C , Permeabilidade , Pele/metabolismo , Solubilidade , TermodinâmicaRESUMO
Detecting high-risk-human papillomavirus (HPV) types has become an integral part of the cervical cancer screening programmes. This study aimed to develop a multiplex polymerase chain reaction (PCR) for identification of HPV types 16 and 18 along with the beta globin gene in formalin-fixed and paraffin-embedded cervical biopsy specimens. A total of 59 samples from patients with cervical abnormalities were tested. HPV 16 positivity was 50% in cervical cancers and 52.9% in cervical intraepithelial neoplasia. Our multiplex PCR protocol can be used as a simple and cost-effective tool for high-risk-HPV detection in cervical cancer screening programmes.